Genetic variants affecting incretin sensitivity and incretin secretion

Diabetologia

Volumn 53, Issue 11, 2010, Pages 2289-2297

  Mussig K ^a   Staiger, H ^a   MacHicao, F ^a   Haring H U ^a   Fritsche, A ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Diabetes mellitus type 2; GIPR; Glucagon like peptide 1; Glucose dependent insulinotropic peptide; Insulin secretion; KCNQ1; Pancreatic beta cell; Review; TCF7L2; WFS1

Indexed keywords

GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON LIKE PEPTIDE 1; GLUCAGON LIKE PEPTIDE 1 RECEPTOR; GLUCOSE; INCRETIN; INSULIN; MEMBRANE PROTEIN; POTASSIUM CHANNEL KCNQ1; PROINSULIN; TRANSCRIPTION FACTOR 7 LIKE 2; UNCLASSIFIED DRUG; WOLFRAMIN;

CELL FUNCTION; GENE IDENTIFICATION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; HUMAN; INSULIN LIKE ACTIVITY; INSULIN RELEASE; MOLECULAR MECHANICS; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; DIABETES MELLITUS, TYPE 2; GASTRIC INHIBITORY POLYPEPTIDE; GENOME-WIDE ASSOCIATION STUDY; GLUCAGON-LIKE PEPTIDE 1; HUMANS; INCRETINS; INSULIN-SECRETING CELLS;

EID: 77957684206     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-010-1876-8     Document Type: Review

References (100)

1. S Wild G Roglic A Green R Sicree H King 2004 Global prevalence of diabetes: estimates for the year 2000 and projections for 2030 Diabetes Care 27 1047 1053 10.2337/diacare.27.5.1047 15111519 (Pubitemid 38579764)
2. SE Kahn 2003 The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes Diabetologia 46 3 19 1:CAS:528:DC%2BD3sXhtVKkt74%3D 10.1007/s00125-003-1190-9 12637977
3. LS Lieberman 2003 Dietary, evolutionary, and modernizing influences on the prevalence of type 2 diabetes Annu Rev Nutr 23 345 377 1:CAS:528: DC%2BD3sXntFSju7s%3D 10.1146/annurev.nutr.23.011702.073212 12651966 (Pubitemid 37059728)
4. R Sladek G Rocheleau J Rung, et al. 2007 A genome-wide association study identifies novel risk loci for type 2 diabetes Nature 445 881 885 1:CAS:528:DC%2BD2sXhvFGiurw%3D 10.1038/nature05616 17293876
5. R Saxena BF Voight V Lyssenko, et al. 2007 Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels Science 316 1331 1336 1:CAS:528:DC%2BD2sXmtVyitrk%3D 10.1126/science.1142358 17463246 (Pubitemid 46871653)
6. E Zeggini MN Weedon CM Lindgren, et al. 2007 Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes Science 316 1336 1341 1:CAS:528:DC%2BD2sXmtVymtb0%3D 10.1126/science.1142364 17463249 (Pubitemid 46871654)
7. LJ Scott KL Mohlke LL Bonnycastle, et al. 2007 A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants Science 316 1341 1345 1:CAS:528:DC%2BD2sXmtVyitrY%3D 10.1126/science.1142382 17463248 (Pubitemid 46871655)
8. V Steinthorsdottir G Thorleifsson I Reynisdottir, et al. 2007 A variant in CDKAL1 influences insulin response and risk of type 2 diabetes Nat Genet 39 770 775 1:CAS:528:DC%2BD2sXlvVSgtL4%3D 10.1038/ng2043 17460697 (Pubitemid 46848592)
9. TM Frayling NJ Timpson MN Weedon, et al. 2007 A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity Science 316 889 894 1:CAS:528:DC%2BD2sXltVentL0%3D 10.1126/science. 1141634 17434869 (Pubitemid 46764279)
10. J Gudmundsson P Sulem V Steinthorsdottir, et al. 2007 Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes Nat Genet 39 977 983 1:CAS:528:DC%2BD2sXot1Cms7Y%3D 10.1038/ng2062 17603485 (Pubitemid 47185170)
11. MS Sandhu MN Weedon KA Fawcett, et al. 2007 Common variants in WFS1 confer risk of type 2 diabetes Nat Genet 39 951 953 1:CAS:528: DC%2BD2sXot1CmsL8%3D 10.1038/ng2067 17603484 (Pubitemid 47185173)
12. E Zeggini LJ Scott R Saxena, et al. 2008 Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes Nat Genet 40 638 645 1:CAS:528:DC%2BD1cXltFylurY%3D 10.1038/ng.120 18372903 (Pubitemid 351601209)
13. H Unoki A Takahashi T Kawaguchi, et al. 2008 SNPs in KCNQ1 are associated with susceptibility to type 2 diabetes in East Asian and European populations Nat Genet 40 1098 1102 1:CAS:528:DC%2BD1cXhtVGgt77E 10.1038/ng.208 18711366
14. K Yasuda K Miyake Y Horikawa, et al. 2008 Variants in KCNQ1 are associated with susceptibility to type 2 diabetes mellitus Nat Genet 40 1092 1097 1:CAS:528:DC%2BD1cXhtVGgt77M 10.1038/ng.207 18711367
15. I Prokopenko C Langenberg JC Florez, et al. 2009 Variants in MTNR1B influence fasting glucose levels Nat Genet 41 77 81 1:CAS:528:DC%2BD1cXhsVKlt7vM 10.1038/ng.290 19060907
16. H Staiger A Stancakova J Zilinskaite, et al. 2008 A candidate type 2 diabetes polymorphism near the HHEX locus affects acute glucose-stimulated insulin release in European populations: results from the EUGENE2 study Diabetes 57 514 517 1:CAS:528:DC%2BD1cXhvVOktLc%3D 10.2337/db07-1254 18039816
17. H Staiger F Machicao N Stefan, et al. 2007 Polymorphisms within novel risk loci for type 2 diabetes determine beta-cell function PLoS One 2 e832 10.1371/journal.pone.0000832 17786204 (Pubitemid 351420086)
18. AF Moore KA Jablonski JB McAteer, et al. 2008 Extension of type 2 diabetes genome-wide association scan results in the diabetes prevention program Diabetes 57 2503 2510 1:CAS:528:DC%2BD1cXhtFSrtrnE 10.2337/db08-0284 18544707
19. N Grarup CS Rose EA Andersson, et al. 2007 Studies of association of variants near the HHEX, CDKN2A/B, and IGF2BP2 genes with type 2 diabetes and impaired insulin release in 10, 705 Danish subjects: validation and extension of genome-wide association studies Diabetes 56 3105 3111 1:CAS:528: DC%2BD2sXhsValurjL 10.2337/db07-0856 17827400 (Pubitemid 350223649)
20. L Pascoe A Tura SK Patel, et al. 2007 Common variants of the novel type 2 diabetes genes CDKAL1 and HHEX/IDE are associated with decreased pancreatic beta-cell function Diabetes 56 3101 3104 1:CAS:528:DC%2BD2sXhsValurjK 10.2337/db07-0634 17804762 (Pubitemid 350223648)
21. K Kirchhoff F Machicao A Haupt, et al. 2008 Polymorphisms in the TCF7L2, CDKAL1 and SLC30A8 genes are associated with impaired proinsulin conversion Diabetologia 51 597 601 1:CAS:528:DC%2BD1cXjsFGiu7o%3D 10.1007/s00125-008-0926-y 18264689
22. R Rong RL Hanson D Ortiz, et al. 2009 Association analysis of variation in/near FTO, CDKAL1, SLC30A8, HHEX, EXT2, IGF2BP2, LOC387761, and CDKN2B with type 2 diabetes and related quantitative traits in Pima Indians Diabetes 58 478 488 1:CAS:528:DC%2BD1MXhslertrs%3D 10.2337/db08-0877 19008344
23. ND Palmer MO Goodarzi CD Langefeld, et al. 2008 Quantitative trait analysis of type 2 diabetes susceptibility loci identified from whole genome association studies in the Insulin Resistance Atherosclerosis Family Study Diabetes 57 1093 1100 1:CAS:528:DC%2BD1cXksVGrsr8%3D 10.2337/db07-1169 18252897
24. MJ Groenewoud JM Dekker A Fritsche, et al. 2008 Variants of CDKAL1 and IGF2BP2 affect first-phase insulin secretion during hyperglycaemic clamps Diabetologia 51 1659 1663 1:CAS:528:DC%2BD1cXpsVGitb4%3D 10.1007/s00125-008- 1083-z 18618095
25. A Stancakova J Pihlajamaki J Kuusisto, et al. 2008 Single-nucleotide polymorphism rs7754840 of CDKAL1 is associated with impaired insulin secretion in nondiabetic offspring of type 2 diabetic subjects and in a large sample of men with normal glucose tolerance J Clin Endocrinol Metab 93 1924 1930 1:CAS:528:DC%2BD1cXlvFWgtrs%3D 10.1210/jc.2007-2218 18285412 (Pubitemid 351656539)
26. L Pascoe TM Frayling MN Weedon, et al. 2008 Beta cell glucose sensitivity is decreased by 39% in non-diabetic individuals carrying multiple diabetes-risk alleles compared with those with no risk alleles Diabetologia 51 1989 1992 1:CAS:528:DC%2BD1cXht1amsrjO 10.1007/s00125-008-1124-7 18719881
27. ND Palmer AB Lehtinen CD Langefeld, et al. 2008 Association of TCF7L2 gene polymorphisms with reduced acute insulin response in Hispanic Americans J Clin Endocrinol Metab 93 304 309 1:CAS:528:DC%2BD1cXnsVygtg%3D%3D 10.1210/jc.2007-1225 17971425
28. J Munoz KH Lok BA Gower, et al. 2006 Polymorphism in the transcription factor 7-like 2 (TCF7L2) gene is associated with reduced insulin secretion in nondiabetic women Diabetes 55 3630 3634 1:CAS:528:DC%2BD28XhtlSmsb3L 10.2337/db06-0574 17130514 (Pubitemid 44923627)
29. R Saxena L Gianniny NP Burtt, et al. 2006 Common single nucleotide polymorphisms in TCF7L2 are reproducibly associated with type 2 diabetes and reduce the insulin response to glucose in nondiabetic individuals Diabetes 55 2890 2895 1:CAS:528:DC%2BD28XhtVGls77M 10.2337/db06-0381 17003358 (Pubitemid 44923692)
30. V Lyssenko CL Nagorny MR Erdos, et al. 2009 Common variant in MTNR1B associated with increased risk of type 2 diabetes and impaired early insulin secretion Nat Genet 41 82 88 1:CAS:528:DC%2BD1cXhsVKlt77J 10.1038/ng.288 19060908
31. H Staiger F Machicao K Kantartzis, et al. 2008 Novel meta-analysis- derived type 2 diabetes risk loci do not determine prediabetic phenotypes PLoS One 3 e3019 10.1371/journal.pone.0003019 18714373
32. H Staiger F Machicao SA Schäfer, et al. 2008 Polymorphisms within the novel type 2 diabetes risk locus MTNR1B determine beta-cell function PLoS One 3 e3962 10.1371/journal.pone.0003962 19088850
33. N Grarup G Andersen NT Krarup, et al. 2008 Association testing of novel type 2 diabetes risk alleles in the JAZF1, CDC123/CAMK1D, TSPAN8, THADA, ADAMTS9, and NOTCH2 loci with insulin release, insulin sensitivity, and obesity in a population-based sample of 4,516 glucose-tolerant middle-aged Danes. Diabetes 57 2534 2540 1:CAS:528:DC%2BD1cXhtFSrtrbO 10.2337/db08-0436 18567820
34. EM Nielsen L Hansen B Carstensen, et al. 2003 The E23K variant of Kir6.2 associates with impaired post-OGTT serum insulin response and increased risk of type 2 diabetes Diabetes 52 573 577 1:CAS:528:DC%2BD3sXhtFansbc%3D 10.2337/diabetes.52.2.573 12540638 (Pubitemid 36173219)
35. T Sparso G Andersen A Albrechtsen, et al. 2008 Impact of polymorphisms in WFS1 on prediabetic phenotypes in a population-based sample of middle-aged people with normal and abnormal glucose regulation Diabetologia 51 1646 1652 1:CAS:528:DC%2BD1cXpsVGiurw%3D 10.1007/s00125-008-1064-2 18568334
36. JC Florez KA Jablonski J McAteer, et al. 2008 Testing of diabetes-associated WFS1 polymorphisms in the Diabetes Prevention Program Diabetologia 51 451 457 1:STN:280:DC%2BD1c3nsFCluw%3D%3D 10.1007/s00125-007- 0891-x 18060660
37. L Wegner MS Hussain K Pilgaard, et al. 2008 Impact of TCF7L2 rs7903146 on insulin secretion and action in young and elderly Danish twins J Clin Endocrinol Metab 93 4013 4019 1:CAS:528:DC%2BD1cXht1GmurrP 10.1210/jc.2008-0855 18611970
38. JL Gonzalez-Sanchez MT Martinez-Larrad C Fernandez-Perez A Kubaszek M Laakso M Serrano-Rios 2003 K121Q PC-1 gene polymorphism is not associated with insulin resistance in a Spanish population Obes Res 11 603 605 1:CAS:528:DC%2BD3sXksVOgtrc%3D 10.1038/oby.2003.86 12740448 (Pubitemid 41151609)
39. RJ Loos PW Franks RW Francis, et al. 2007 TCF7L2 polymorphisms modulate proinsulin levels and beta-cell function in a British Europid population Diabetes 56 1943 1947 1:CAS:528:DC%2BD2sXnvVWisrc%3D 10.2337/db07-0055 17416797 (Pubitemid 47025464)
40. ES Stolerman AK Manning JB McAteer, et al. 2009 TCF7L2 variants are associated with increased proinsulin/insulin ratios but not obesity traits in the Framingham Heart Study Diabetologia 52 614 620 1:CAS:528: DC%2BD1MXisFSjur8%3D 10.1007/s00125-009-1266-2 19183934
41. JJ Holst T Vilsboll CF Deacon 2009 The incretin system and its role in type 2 diabetes mellitus Mol Cell Endocrinol 297 127 136 1:CAS:528: DC%2BD1cXhsFajt73P 10.1016/j.mce.2008.08.012 18786605
42. JJ Meier MA Nauck 2010 Is the diminished incretin effect in type 2 diabetes just an epi-phenomenon of impaired beta-cell function? Diabetes 59 1117 1125 1:CAS:528:DC%2BC3cXmtFegsLc%3D 10.2337/db09-1899 20427697
43. T Jin 2008 The WNT signalling pathway and diabetes mellitus Diabetologia 51 1771 1780 1:CAS:528:DC%2BD1cXhtVOnurzF 10.1007/s00125-008-1084-y 18696049
44. F Figeac B Uzan M Faro N Chelali B Portha J Movassat 2010 Neonatal growth and regeneration of β cells are regulated by the Wnt/β-catenin signaling in normal and diabetic rats Am J Physiol Endocrinol Metab 298 E245 E256 1:CAS:528:DC%2BC3cXhvVyku7g%3D 10.1152/ajpendo.00538.2009 19920216
45. T Jin 2008 Mechanisms underlying proglucagon gene expression J Endocrinol 198 17 28 1:CAS:528:DC%2BD1cXpt12ls7s%3D 10.1677/JOE-08-0085 18577568 (Pubitemid 352038181)
46. Z Liu JF Habener 2008 Glucagon-like peptide-1 activation of TCF7L2-dependent Wnt signaling enhances pancreatic beta cell proliferation J Biol Chem 283 8723 8735 1:CAS:528:DC%2BD1cXjsFCgt7o%3D 10.1074/jbc.M706105200 18216022
47. M Bordonaro 2009 Role of Wnt signaling in the development of type 2 diabetes Vitam Horm 80 563 581 1:CAS:528:DC%2BD1MXptlSitLY%3D 10.1016/S0083-6729(08)00619-5 19251050
48. MK Loder XG da Silva A McDonald GA Rutter 2008 TCF7L2 controls insulin gene expression and insulin secretion in mature pancreatic beta-cells Biochem Soc Trans 36 357 359 1:CAS:528:DC%2BD1cXmtVKlsLk%3D 10.1042/BST0360357 18481957 (Pubitemid 351839331)
49. L Shu AV Matveyenko J Kerr-Conte JH Cho CH McIntosh K Maedler 2009 Decreased TCF7L2 protein levels in type 2 diabetes mellitus correlate with downregulation of GIP- and GLP-1 receptors and impaired beta-cell function Hum Mol Genet 18 2388 2399 1:CAS:528:DC%2BD1MXnt1ehtL0%3D 10.1093/hmg/ddp178 19386626
50. V Lyssenko R Lupi P Marchetti, et al. 2007 Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes J Clin Invest 117 2155 2163 1:CAS:528:DC%2BD2sXoslOnsrk%3D 10.1172/JCI30706 17671651 (Pubitemid 47219560)
51. L Shu NS Sauter FT Schulthess AV Matveyenko J Oberholzer K Maedler 2008 Transcription factor 7-like 2 regulates beta-cell survival and function in human pancreatic islets Diabetes 57 645 653 1:CAS:528:DC%2BD1cXjt1Chtbo%3D 10.2337/db07-0847 18071026
52. XG da Silva MK Loder A McDonald, et al. 2009 TCF7L2 regulates late events in insulin secretion from pancreatic islet beta-cells Diabetes 58 894 905 10.2337/db09-0166
53. SF Grant G Thorleifsson I Reynisdottir, et al. 2006 Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes Nat Genet 38 320 323 1:CAS:528:DC%2BD28XhslCjtrw%3D 10.1038/ng1732 16415884
54. JC Florez KA Jablonski N Bayley, et al. 2006 TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program N Engl J Med 355 241 250 1:CAS:528:DC%2BD28XntVWktrw%3D 10.1056/NEJMoa062418 16855264 (Pubitemid 44079339)
55. A Helgason S Palsson G Thorleifsson, et al. 2007 Refining the impact of TCF7L2 gene variants on type 2 diabetes and adaptive evolution Nat Genet 39 218 225 1:CAS:528:DC%2BD2sXpvFeqsA%3D%3D 10.1038/ng1960 17206141 (Pubitemid 46184353)
56. LJ Scott LL Bonnycastle CJ Willer, et al. 2006 Association of transcription factor 7-like 2 (TCF7L2) variants with type 2 diabetes in a Finnish sample Diabetes 55 2649 2653 1:CAS:528:DC%2BD28XpsVOqs70%3D 10.2337/db06-0341 16936217 (Pubitemid 44871169)
57. CM Damcott TI Pollin LJ Reinhart, et al. 2006 Polymorphisms in the transcription factor 7-like 2 (TCF7L2) gene are associated with type 2 diabetes in the Amish: replication and evidence for a role in both insulin secretion and insulin resistance Diabetes 55 2654 2659 1:CAS:528:DC%2BD28XpsVOqs7g%3D 10.2337/db06-0338 16936218 (Pubitemid 44871170)
58. SA Schäfer O Tschritter F Machicao, et al. 2007 Impaired glucagon-like peptide-1-induced insulin secretion in carriers of transcription factor 7-like 2 (TCF7L2) gene polymorphisms Diabetologia 50 2443 2450 10.1007/s00125-007-0753-6 17661009 (Pubitemid 350060632)
59. DT Villareal H Robertson GI Bell, et al. 2010 TCF7L2 variant rs7903146 affects the risk of type 2 diabetes by modulating incretin action Diabetes 59 479 485 1:CAS:528:DC%2BC3cXhvVyru7Y%3D 10.2337/db09-1169 19934000
60. K Pilgaard CB Jensen JH Schou, et al. 2009 The T allele of rs7903146 TCF7L2 is associated with impaired insulinotropic action of incretin hormones, reduced 24 h profiles of plasma insulin and glucagon, and increased hepatic glucose production in young healthy men Diabetologia 52 1298 1307 1:CAS:528:DC%2BD1MXms1yhs70%3D 10.1007/s00125-009-1307-x 19288077
61. C Knauf PD Cani C Perrin, et al. 2005 Brain glucagon-like peptide-1 increases insulin secretion and muscle insulin resistance to favor hepatic glycogen storage J Clin Invest 115 3554 3563 1:CAS:528:DC%2BD2MXhtlSqtLvL 10.1172/JCI25764 16322793 (Pubitemid 43121843)
62. R Saxena MF Hivert C Langenberg, et al. 2010 Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge Nat Genet 42 142 148 1:CAS:528:DC%2BC3cXntVCksw%3D%3D 10.1038/ng.521 20081857
63. T Yaqub IG Tikhonova J Lattig, et al. 2010 Identification of determinants of glucose-dependent insulinotropic polypeptide receptor that interact with N-terminal biologically active region of the natural ligand Mol Pharmacol 77 547 558 1:CAS:528:DC%2BC3cXkvVykur8%3D 10.1124/mol.109.060111 20061446
64. D Gupta M Peshavaria N Monga TL Jetton JL Leahy 2010 Physiologic and pharmacologic modulation of GIP receptor expression in ss-cells by PPARgamma signaling: possible mechanism for the GIP resistance in type 2 diabetes Diabetes 59 1445 1450 1:CAS:528:DC%2BC3cXotFGkurs%3D 10.2337/db09-1655 20332343
65. K Miyawaki Y Yamada H Yano, et al. 1999 Glucose intolerance caused by a defect in the entero-insular axis: a study in gastric inhibitory polypeptide receptor knockout mice Proc Natl Acad Sci USA 96 14843 14847 1:CAS:528:DC%2BD3cXhtFansg%3D%3D 10.1073/pnas.96.26.14843 10611300 (Pubitemid 30019727)
66. S Renner C Fehlings N Herbach, et al. 2010 Glucose intolerance and reduced proliferation of pancreatic beta-cells in transgenic pigs with impaired glucose-dependent insulinotropic polypeptide function Diabetes 59 1228 1238 1:CAS:528:DC%2BC3cXmtFegtrw%3D 10.2337/db09-0519 20185813
67. SB Widenmaier SJ Kim GK Yang, et al. 2010 A GIP receptor agonist exhibits beta-cell anti-apoptotic actions in rat models of diabetes resulting in improved beta-cell function and glycemic control PLoS One 5 e9590 10.1371/journal.pone.0009590 20231880
68. K Almind L Ambye SA Urhammer, et al. 1998 Discovery of amino acid variants in the human glucose-dependent insulinotropic polypeptide (GIP) receptor: the impact on the pancreatic beta cell responses and functional expression studies in Chinese hamster fibroblast cells Diabetologia 41 1194 1198 1:CAS:528:DyaK1cXmtlaisrg%3D 10.1007/s001250051051 9794107 (Pubitemid 28449086)
69. A Kubota Y Yamada T Hayami, et al. 1996 Identification of two missense mutations in the GIP receptor gene: a functional study and association analysis with NIDDM: no evidence of association with Japanese NIDDM subjects Diabetes 45 1701 1705 1:CAS:528:DyaK28XntlCltrs%3D 10.2337/diabetes.45.12.1701 8922354
70. I Nitz E Fisher C Weikert, et al. 2007 Association analyses of GIP and GIPR polymorphisms with traits of the metabolic syndrome Mol Nutr Food Res 51 1046 1052 1:CAS:528:DC%2BD2sXhtVSgtb7N 10.1002/mnfr.200700048 17624916 (Pubitemid 47292278)
71. SA Schäfer K Müssig H Staiger, et al. 2009 A common genetic variant in WFS1 determines impaired glucagon-like peptide-1-induced insulin secretion Diabetologia 52 1075 1082 10.1007/s00125-009-1344-5 19330314
72. AM Simonis-Bik G Nijpels TW van Haeften, et al. 2010 Gene variants in the novel type 2 diabetes loci CDC123/CAMK1D, THADA, ADAMTS9, BCL11A, and MTNR1B affect different aspects of pancreatic beta-cell function Diabetes 59 293 301 1:CAS:528:DC%2BC3cXmtVKlsA%3D%3D 10.2337/db09-1048 19833888
73. K Takeda H Inoue Y Tanizawa, et al. 2001 WFS1 (Wolfram syndrome 1) gene product: predominant subcellular localization to endoplasmic reticulum in cultured cells and neuronal expression in rat brain Hum Mol Genet 10 477 484 1:CAS:528:DC%2BD3MXhslSitLs%3D 10.1093/hmg/10.5.477 11181571
74. H Ishihara S Takeda A Tamura, et al. 2004 Disruption of the WFS1 gene in mice causes progressive beta-cell loss and impaired stimulus-secretion coupling in insulin secretion Hum Mol Genet 13 1159 1170 1:CAS:528:DC%2BD2cXktVWgsrs%3D 10.1093/hmg/ddh125 15056606 (Pubitemid 38786998)
75. AC Riggs E Bernal-Mizrachi M Ohsugi, et al. 2005 Mice conditionally lacking the Wolfram gene in pancreatic islet beta cells exhibit diabetes as a result of enhanced endoplasmic reticulum stress and apoptosis Diabetologia 48 2313 2321 1:STN:280:DC%2BD2MngsValtQ%3D%3D 10.1007/s00125-005-1947-4 16215705 (Pubitemid 41618923)
76. T Yamada H Ishihara A Tamura, et al. 2006 WFS1-deficiency increases endoplasmic reticulum stress, impairs cell cycle progression and triggers the apoptotic pathway specifically in pancreatic beta-cells Hum Mol Genet 15 1600 1609 1:CAS:528:DC%2BD28XktlSisbs%3D 10.1093/hmg/ddl081 16571599 (Pubitemid 43904826)
77. R Xu B Xia J Geng, et al. 2009 Expression and localization of Wolfram syndrome 1 gene in the developing rat pancreas World J Gastroenterol 15 5425 5431 1:CAS:528:DC%2BD1MXhsVKltLzN 10.3748/wjg.15.5425 19916172
78. D Scheuner RJ Kaufman 2008 The unfolded protein response: a pathway that links insulin demand with beta-cell failure and diabetes Endocr Rev 29 317 333 1:CAS:528:DC%2BD1cXntV2lsbs%3D 10.1210/er.2007-0039 18436705 (Pubitemid 351679702)
79. SG Fonseca M Fukuma KL Lipson, et al. 2005 WFS1 is a novel component of the unfolded protein response and maintains homeostasis of the endoplasmic reticulum in pancreatic beta-cells J Biol Chem 280 39609 39615 1:CAS:528:DC%2BD2MXht1ems7%2FI 10.1074/jbc.M507426200 16195229 (Pubitemid 41713920)
80. SJ Marciniak D Ron 2006 Endoplasmic reticulum stress signaling in disease Physiol Rev 86 1133 1149 1:CAS:528:DC%2BD28Xht1SgtLzN 10.1152/physrev.00015. 2006 17015486 (Pubitemid 44521649)
81. A Jonsson B Isomaa T Tuomi, et al. 2009 A variant in the KCNQ1 gene predicts future type 2 diabetes and mediates impaired insulin secretion Diabetes 58 2409 2413 1:CAS:528:DC%2BD1MXht1yrsr%2FL 10.2337/db09-0246 19584308
82. K Müssig H Staiger F Machicao, et al. 2009 Association of type 2 diabetes candidate polymorphisms in KCNQ1 with incretin and insulin secretion Diabetes 58 1715 1720 10.2337/db08-1589 19366866
83. J Holmkvist K Banasik G Andersen, et al. 2009 The type 2 diabetes associated minor allele of rs2237895 KCNQ1 associates with reduced insulin release following an oral glucose load PLoS One 4 e5872 10.1371/journal.pone. 0005872 19516902
84. JT Tan S Nurbaya D Gardner S Ye ES Tai DP Ng 2009 Genetic variation in KCNQ1 associates with fasting glucose and beta-cell function: a study of 3,734 subjects comprising three ethnicities living in Singapore Diabetes 58 1445 1449 1:CAS:528:DC%2BD1MXntFanu7k%3D 10.2337/db08-1138 19252135
85. JA Towbin M Vatta 2001 Molecular biology and the prolonged QT syndromes Am J Med 110 385 398 1:CAS:528:DC%2BD3MXisVWns7c%3D 10.1016/S0002-9343(00)00715- 4 11286954 (Pubitemid 32245811)
86. F Thevenod 2002 Ion channels in secretory granules of the pancreas and their role in exocytosis and release of secretory proteins Am J Physiol Cell Physiol 283 C651 C672 1:CAS:528:DC%2BD38XntFOntL4%3D 12176723
87. S Ullrich J Su F Ranta, et al. 2005 Effects of I(Ks) channel inhibitors in insulin-secreting INS-1 cells Pflugers Arch 451 428 436 1:CAS:528: DC%2BD2MXht1GlsLfP 10.1007/s00424-005-1479-2 16133261 (Pubitemid 41719574)
88. V Vallon F Grahammer H Volkl, et al. 2005 KCNQ1-dependent transport in renal and gastrointestinal epithelia Proc Natl Acad Sci USA 102 17864 17869 1:CAS:528:DC%2BD2MXhtlegs7jM 10.1073/pnas.0505860102 16314573 (Pubitemid 41803588)
89. J Dupuis C Langenberg I Prokopenko, et al. 2010 New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk Nat Genet 42 105 116 1:CAS:528:DC%2BC3cXntVCqsw%3D%3D 10.1038/ng.520 20081858
90. JK Wolford KA Yeatts SK Dhanjal, et al. 2005 Sequence variation in PPARG may underlie differential response to troglitazone Diabetes 54 3319 3325 1:CAS:528:DC%2BD2MXht1Shsr%2FP 10.2337/diabetes.54.11.3319 16249460 (Pubitemid 43334389)
91. ES Kang SY Park HJ Kim, et al. 2005 Effects of Pro12Ala polymorphism of peroxisome proliferator-activated receptor gamma2 gene on rosiglitazone response in type 2 diabetes Clin Pharmacol Ther 78 202 208 1:CAS:528: DC%2BD2MXnslyhtbo%3D 10.1016/j.clpt.2005.04.013 16084854 (Pubitemid 41112288)
92. M Blüher G Lubben R Paschke 2003 Analysis of the relationship between the Pro12Ala variant in the PPAR-gamma2 gene and the response rate to therapy with pioglitazone in patients with type 2 diabetes Diabetes Care 26 825 831 10.2337/diacare.26.3.825 12610044 (Pubitemid 36929350)
93. S Snitker RM Watanabe I Ani, et al. 2004 Changes in insulin sensitivity in response to troglitazone do not differ between subjects with and without the common, functional Pro12Ala peroxisome proliferator-activated receptor-gamma2 gene variant: results from the Troglitazone in Prevention of Diabetes (TRIPOD) study Diabetes Care 27 1365 1368 1:CAS:528:DC%2BD2cXlt1ylur4%3D 10.2337/diacare.27.6.1365 15161789 (Pubitemid 38679984)
94. JC Florez KA Jablonski MW Sun, et al. 2007 Effects of the type 2 diabetes-associated PPARG P12A polymorphism on progression to diabetes and response to troglitazone J Clin Endocrinol Metab 92 1502 1509 1:CAS:528:DC%2BD2sXksVSrtb4%3D 10.1210/jc.2006-2275 17213274 (Pubitemid 46556431)
95. G Sesti E Laratta M Cardellini, et al. 2006 The E23K variant of KCNJ11 encoding the pancreatic beta-cell adenosine 5′-triphosphate-sensitive potassium channel subunit Kir6.2 is associated with an increased risk of secondary failure to sulfonylurea in patients with type 2 diabetes. J Clin Endocrinol Metab 91 2334 2339 1:CAS:528:DC%2BD28XlvVCgtrc%3D
96. JC Florez KA Jablonski SE Kahn, et al. 2007 Type 2 diabetes-associated missense polymorphisms KCNJ11 E23K and ABCC8 A1369S influence progression to diabetes and response to interventions in the Diabetes Prevention Program Diabetes 56 531 536 1:CAS:528:DC%2BD2sXhs1ajtrs%3D 10.2337/db06-0966 17259403
97. M Yu XJ Xu JY Yin, et al. 2010 KCNJ11 Lys23Glu and TCF7L2 rs290487(C/T) polymorphisms affect therapeutic efficacy of repaglinide in Chinese patients with type 2 diabetes Clin Pharmacol Ther 87 330 335 1:CAS:528: DC%2BC3cXitVSqtLc%3D 10.1038/clpt.2009.242 20054294
98. AL Gloyn Y Hashim SJ Ashcroft R Ashfield S Wiltshire RC Turner 2001 Association studies of variants in promoter and coding regions of beta-cell ATP-sensitive K-channel genes SUR1 and Kir6.2 with Type 2 diabetes mellitus (UKPDS 53) Diabet Med 18 206 212 1:CAS:528:DC%2BD3MXjslKnsL4%3D 10.1046/j.1464-5491.2001.00449.x 11318841 (Pubitemid 32397858)
99. CH Kimber AS Doney ER Pearson, et al. 2007 TCF7L2 in the Go-DARTS study: evidence for a gene dose effect on both diabetes susceptibility and control of glucose levels Diabetologia 50 1186 1191 1:CAS:528:DC%2BD2sXkvFKju74%3D 10.1007/s00125-007-0661-9 17429603 (Pubitemid 46701564)
100. ER Pearson LA Donnelly C Kimber, et al. 2007 Variation in TCF7L2 influences therapeutic response to sulfonylureas: a GoDARTs study Diabetes 56 2178 2182 1:CAS:528:DC%2BD2sXos12qsbk%3D 10.2337/db07-0440 17519421 (Pubitemid 47195841)